EndoTAG-1+GEM vs GEM in Patients With Locally Advanced/Metastatic Pancreatic Adenocarcinoma Failed on FOLFIRINOX

PHASE3CompletedINTERVENTIONAL
Enrollment

218

Participants

Timeline

Start Date

October 16, 2018

Primary Completion Date

July 30, 2021

Study Completion Date

October 8, 2021

Conditions
Metastatic Pancreas CancerLocally Advanced Pancreatic CancerPancreatic Adenocarcinoma
Interventions
DRUG

EndoTAG-1

twice weekly

DRUG

Gemcitabine

once weekly

Trial Locations (68)

22908

University of Virginia Hospital, Charlottesville

29406

Charleston Cancer Center, North Charleston

30322

Emory University Hospital, Atlanta

31904

John B. Amos Cancer Center / IACT Health, Columbus

38801

North Mississippi Hematology & Oncology Associates, Ltd., Tupelo

48201

Karmanos Cancer Institute, Detroit

48202

Henry Ford Hospital, Detroit

60077

Orchard Healthcare Research (OHR) Inc., Skokie

66046

CH Saint Jean, Perpignan

66606

Cotton O'Neil Cancer Center (Stormont-Vail Cancer Center), Topeka

68510

Southeast Nebraska Cancer Center (SNCC) - Central Clinic - Main Clinic, Lincoln

76104

The Center for Cancer and Blood Disorders, Fort Worth

76508

Scott & White Vasicek Cancer Treatment Center, Temple

77380

Renovatioclinical, The Woodlands

92879

Compassionate Cancer Care Medical Group, Inc, Corona

46260-2082

Investigator Clinical Research Centers of Indiana, Indianapolis

18840-1625

Guthrie - Corning Hospital - Guthrie Cancer Center, Sayre

Unknown

CHU Angers, Angers

CHRU - Besançon, Besançon

Hopital Haut Leveque, Bordeaux

CHRU Brest - Hôpital Morvan, Brest

Centre Hospitalier de Cholet, Cholet

Centre Georges François Leclerc, Dijon

Centre Hospitalier Départemental, La Roche-sur-Yon

Hôpital Privé Jean Mermoz, Lyon

La Timone, Marseille

Institut de Cancérologie de Lorraine, Nancy

Centre Antoine-Lacassagne, Nice

Hopital La Pitié Salpétrière, Paris

Centre Eugène Marquis, Rennes

Clinique Sainte Anne/Strasbourg Oncologie Leberale, Strasbourg

Dél-pesti Centrumkórház - Országos Hematológia és Infektológia Intézet, Budapest

Magyar Honvédség Egészségügyi Központ, Budapest

Országos Onkológiai Intézet, Budapest

Bács-Kiskun Megyei Kórház Onkoradiológiai Központ, Kecskemét

Borsod-Abaúj-Zemplén Megyei Központi Kórház és Egyetemi Oktatókórház, Miskolc

Pécsi Tudomány Egyetem Onkoterápiás Intézet, Pécs

Oncology Department, Hillel Yafe MC, Hadera

Rambam Health Center, Haifa

Meir Medical Center, Kfar Saba

Rabin MC, Petah Tikva

Tel Aviv Sourasky Medical Center, Tel Aviv

Arkhangelsk Clinical Oncological Dispensary, Arkhangelsk

Kursk State Clinical Oncology Dispensary, Kursk

"Federal State Budgetary Scientific Institution Russian Oncological Scientific Center named after N.N.Blokhin", Moscow

"Private clinnic Medicine 24/7", Moscow

"Budget Institution of Healthcare of Omsk Region Clinical Oncology Dispensary", Omsk

"State Budget Healthcare Institution Orenburg Region Clinical Oncological Dispensary", Orenburg

State Budgetary Healthcare Institution Leningrad Regional Oncology Center, Saint Petersburg

Chungnam National University Hospital, Daejeon

National Cancer Center, Goyang-si

Inha University Hospital, Incheon

Chonnam National University Hwasun Hospital, Jeongnam

CHA Bundang Medical Center, Seongnam

Korea University Guro Hospital, Seoul

Samsung Medical Center, Seoul

Severance Hospital, Seoul

Ajou University Hospital, Suwon

Changhua Christian Hospital, Changhua

Chang Gung Medical Foundation - Kaohsiung Branch, Kaohsiung City

E-Da Hospital, Kaohsiung City

China Medical University Hospital, Taichung

National Cheng Kung University Hospital, Tainan City

Mackay Memorial Hospital-Taipei Branch, Taipei

National Taiwan University Hospital, Taipei

Taipei Veterans General Hospital, Taipei

Tri-Service General Hospital (TSGH), Taipei

Chang Gung Medical Foundation - Linkou Branch, Taoyuan District

All Listed Sponsors
lead

SynCore Biotechnology Co., Ltd.

INDUSTRY

NCT03126435 - EndoTAG-1+GEM vs GEM in Patients With Locally Advanced/Metastatic Pancreatic Adenocarcinoma Failed on FOLFIRINOX | Biotech Hunter | Biotech Hunter